MX2023000947A - Peptidos grapados y metodos para su obtencion. - Google Patents
Peptidos grapados y metodos para su obtencion.Info
- Publication number
- MX2023000947A MX2023000947A MX2023000947A MX2023000947A MX2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A
- Authority
- MX
- Mexico
- Prior art keywords
- present disclosure
- disclosure provides
- catenin
- beta
- agents
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000015735 Beta-catenin Human genes 0.000 abstract 3
- 108060000903 Beta-catenin Proteins 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000005516 engineering process Methods 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055308P | 2020-07-22 | 2020-07-22 | |
| US202163208494P | 2021-06-08 | 2021-06-08 | |
| PCT/US2021/042856 WO2022020652A2 (en) | 2020-07-22 | 2021-07-22 | Stapled peptides and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023000947A true MX2023000947A (es) | 2023-02-22 |
Family
ID=79728982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023000947A MX2023000947A (es) | 2020-07-22 | 2021-07-22 | Peptidos grapados y metodos para su obtencion. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240116985A1 (https=) |
| EP (1) | EP4185599A4 (https=) |
| JP (1) | JP2023535026A (https=) |
| KR (1) | KR20230057350A (https=) |
| CN (1) | CN116323638A (https=) |
| AU (1) | AU2021314310A1 (https=) |
| CA (1) | CA3186681A1 (https=) |
| IL (1) | IL299907A (https=) |
| MX (1) | MX2023000947A (https=) |
| WO (1) | WO2022020652A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018329956A1 (en) | 2017-09-07 | 2020-08-20 | Fog Pharmaceuticals, Inc. | Agents modulating beta-catenin functions and methods thereof |
| MX2021001943A (es) | 2018-08-20 | 2021-07-15 | Fog Pharmaceuticals Inc | Colecciones de péptidos, agentes peptídicos y métodos de uso de los mismos. |
| KR20240031957A (ko) * | 2021-06-08 | 2024-03-08 | 포그 파마슈티컬스 인코포레이티드 | 스테이플화된 펩티드 및 이의 방법 |
| CN115260060A (zh) * | 2022-09-07 | 2022-11-01 | 康化（上海）新药研发有限公司 | (2s)-2-n-芴甲氧羰基氨基-5,5-二甲基正亮氨酸的合成方法 |
| WO2024054892A1 (en) * | 2022-09-09 | 2024-03-14 | Shape Therapeutics Inc. | Therapeutic peptides |
| WO2024130217A1 (en) * | 2022-12-15 | 2024-06-20 | Fog Pharmaceuticals, Inc. | Stapled peptides and methods thereof |
| CN120529912A (zh) * | 2022-12-15 | 2025-08-22 | 帕拉比利斯药物公司 | 订书钉化肽及其方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5671196A (en) * | 1996-03-28 | 1997-10-17 | Immulogic Pharmaceutical Corporation | Myelin oligodendrocyte glycoprotein peptides and uses thereof |
| US20040181830A1 (en) * | 2001-05-07 | 2004-09-16 | Kovalic David K. | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| US20050187147A1 (en) * | 2003-09-22 | 2005-08-25 | Newman Michael J. | Compositions and methods for increasing drug efficiency |
| EP2254592B1 (en) * | 2008-02-28 | 2019-06-05 | Dako Denmark A/S | Mhc multimers in borrelia diagnostics and disease |
| WO2010009987A2 (en) * | 2008-07-21 | 2010-01-28 | Probiodrug Ag | Diagnostic antibody assay |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| WO2012040459A2 (en) * | 2010-09-22 | 2012-03-29 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| WO2014026033A1 (en) * | 2012-08-08 | 2014-02-13 | University Of Florida Research Foundation, Inc. | Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats |
| GB2563875B (en) * | 2017-06-28 | 2020-08-19 | Sutura Therapeutics Ltd | Improvements in drug delivery |
| AU2018329956A1 (en) * | 2017-09-07 | 2020-08-20 | Fog Pharmaceuticals, Inc. | Agents modulating beta-catenin functions and methods thereof |
| WO2019178313A1 (en) * | 2018-03-14 | 2019-09-19 | Dana-Farber Cancer Institute, Inc. | Stabilized peptides for biomarker detection |
-
2021
- 2021-07-22 AU AU2021314310A patent/AU2021314310A1/en not_active Abandoned
- 2021-07-22 JP JP2023504288A patent/JP2023535026A/ja active Pending
- 2021-07-22 WO PCT/US2021/042856 patent/WO2022020652A2/en not_active Ceased
- 2021-07-22 CA CA3186681A patent/CA3186681A1/en active Pending
- 2021-07-22 IL IL299907A patent/IL299907A/en unknown
- 2021-07-22 MX MX2023000947A patent/MX2023000947A/es unknown
- 2021-07-22 KR KR1020237005577A patent/KR20230057350A/ko active Pending
- 2021-07-22 CN CN202180064601.7A patent/CN116323638A/zh active Pending
- 2021-07-22 US US18/017,024 patent/US20240116985A1/en active Pending
- 2021-07-22 EP EP21847152.2A patent/EP4185599A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023535026A (ja) | 2023-08-15 |
| WO2022020652A3 (en) | 2022-03-03 |
| AU2021314310A1 (en) | 2023-03-16 |
| CN116323638A (zh) | 2023-06-23 |
| KR20230057350A (ko) | 2023-04-28 |
| EP4185599A4 (en) | 2024-08-28 |
| CA3186681A1 (en) | 2022-01-27 |
| US20240116985A1 (en) | 2024-04-11 |
| IL299907A (en) | 2023-03-01 |
| EP4185599A2 (en) | 2023-05-31 |
| WO2022020652A2 (en) | 2022-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023000947A (es) | Peptidos grapados y metodos para su obtencion. | |
| BR112023025528A2 (pt) | Peptídeos grampeados e métodos destes | |
| PH12022550932A1 (en) | Glp-1r modulating compounds | |
| MX2020002435A (es) | Agentes que modulan las funciones de beta-catenina y sus métodos. | |
| PH12022552122A1 (en) | Antibodies and fusion proteins that bind to ccr8 and uses thereof | |
| PH12023552860A1 (en) | Carboxy-benzimidazole glp-1r modulating compounds | |
| WO2019178269A3 (en) | Antibodies that bind cd39 and uses thereof | |
| PH12016500081B1 (en) | Immunoglobulin variants and uses thereof | |
| PE20220505A1 (es) | Moleculas de union a tigit y pd-1/tigit | |
| SG170793A1 (en) | Anti-mn antibodies and methods of using same | |
| MY205398A (en) | Variants of cd38 antibody and uses thereof | |
| ES2675375T3 (es) | Anticuerpos monoclonales contra claudina 18 para el tratamiento del cáncer | |
| NZ553701A (en) | Composition comprising SC03-014 and SC03-022 antibodies against SARS-CoV | |
| EA200901067A1 (ru) | Использование семафорина 6а в качестве промотора миелинизации и дифференцировки олигодендроцитов | |
| EA202190708A1 (ru) | Модуляторы экспрессии pnpla3 | |
| NZ755083A (en) | Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis | |
| EA201890320A1 (ru) | Молекулы антител, которые связывают cd79 | |
| WO2017040380A3 (en) | Engineered antibody fc variants | |
| ZA202208280B (en) | Antibody molecules to c5ar1 and uses thereof | |
| AU2019321490A8 (en) | Ox40-binding polypeptides and uses thereof | |
| AU2021269176A8 (en) | Single domain antibodies binding to SARS-CoV-2 spike protein | |
| PH12021553306A1 (en) | Anti-new york esophageal squamous cell carcinoma 1 (ny-eso-1) antigen-binding proteins and methods of use thereof | |
| MX2022006689A (es) | Métodos de tratamiento usando proteínas de unión al transcrito 7 similar a inmunoglobulina (ilt7). | |
| MX2022011077A (es) | Variantes de transglutaminasa. | |
| CN116669770A8 (zh) | 甲基丙烯酰胺蛋白质结合剂及其用途 |